Biomechanical Changes After In Vivo Collagen Cross-Linking With Rose Bengal–Green Light and Riboflavin-UVA-Reference-Cited by-同舟云学术

Biomechanical Changes After In Vivo Collagen Cross-Linking With Rose Bengal–Green Light and Riboflavin-UVA

Published:2017-03-15 Issue:3 Volume:58 Page:1612
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Bekesi Nandor¹,Gallego-Muñoz Patricia²,Ibarés-Frías Lucía²,Perez-Merino Pablo¹,Martinez-Garcia M. Carmen²,Kochevar Irene E.³,Marcos Susana¹

Affiliation:

1. Instituto de Optica, Consejo Superior de Investigaciones Cientificas, Madrid, Spain

2. Departamento de Biología Celular, Histología y Farmacología, GIR de Técnicas Ópticas para el Diagnóstico, Universidad de Valladolid, Valladolid, Spain

3. Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthamoeba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) study;Trials;2024-08-28

2. A simple computational model for scleral stiffness assessments via air-puff deformation OCT;Frontiers in Bioengineering and Biotechnology;2024-07-30

3. Non-contact tonometry: predicting intraocular pressure using a material—corneal thickness—independent methodology;Frontiers in Bioengineering and Biotechnology;2024-07-25

4. Effects of Different Scleral Photo-Crosslinking Modalities on Scleral Stiffness and Hydration;Investigative Ophthalmology & Visual Science;2024-07-03

5. A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthameoba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) Study;2024-07-02